Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:00 AM
Ignite Modification Date:
2025-12-25 @ 2:00 AM
NCT ID:
NCT00383994
Eligibility Criteria:
Inclusion Criteria:
1. Patients with previous diagnosis of CD20+ B-cell CLL and non-Hodgkin's lymphoma who have failed standard conventional chemotherapy, and who had persistent disease at 3 months, or progressive disease after non-myeloablative allogeneic transplantation.
2. Donor willingness to donate peripheral blood (same donor of the original transplant).
3. Negative Beta HCG in a woman with child bearing potential defined as not post-menopausal for 12 months or not previous surgical sterilization.
Exclusion Criteria:
1. Pregnancy or lactation
2. HIV , HTLV-I or hepatitis.
3. Active infection(s) \>/= grade 3.
4. Severe active concomitant medical or psychiatric illness.
5. Concurrent active GVHD requiring tacrolimus.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT00383994
Study Brief:
Protocol Section:
NCT00383994